Needham, MA (PRWEB) February 13, 2009
The Pharmaceutical Strategy Series, a division of Cambridge Healthtech Institute, recently posted details for its next executive forum - Combination Products: Improving Product Life Cycles, Extending Lines, and Creating Novel Therapeutics to be held on June 1-2, 2009 at the Royal Sonesta Hotel in Cambridge, MA. This executive forum will focus on the practical interplay between combination product research, development challenges, and commercial and partnering strategies, as well as the implications for successful market realization.
Session Topics include:
- Creative Product Development, Portfolio Management, and Line Extension Strategies using Combination Products
- Regulatory Implications - Anticipating Regulatory Hurdles and New Developments
- The Market Advantage of Combination Products - Analysis and Strategies for Positioning
- Commercial Strategies for Success - Market Acceptance and Reimbursement
- Development Challenges of Combination Products
According to Micah Lieberman, Executive Director of the Pharmaceutical Strategy Series, "We are delighted to have organized this executive forum for the pharmaceutical, biologics and medical devices industries to help companies leverage new business opportunities and intellectual property for their existing (and future) products. Pharmaceutical Strategy Series' executive forums have become known as networking platforms that bring together senior-level executives, analysts, and industry experts. I am also pleased to announce the support of Epstein Becker & Green, P.C. as our sponsor," states Lieberman.
Bradley Merrill Thompson, General Counsel to the Combination Products Coalition and Shareholder at Epstein Becker & Green, P.C. commented: "We look forward to present our perspective on overcoming the regulatory hurdles with combination products. To be compliant and competitive in the marketplace, combination product companies must stay current with regulatory developments and initiatives impacting the combination product industry. Delegates attending this conference will be better positioned to ensure the success of their company's combination products," says Thompson.
Prior to the start of this executive forum will be a pre-conference workshop: Economic Value-Based Product Design for Combination Drugs.
For full details and to register for the conference and/or pre-conference workshop, visit http://www.healthtech.com/CTX/overview.aspx
To receive a press pass, email Tracey Fielding at firstname.lastname@example.org
About Cambridge Healthtech Institute
Founded in 1992, Cambridge Healthtech Institute (http://www.chicorporate.com) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.
Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.
About The Pharmaceutical Strategy Series
A division of Cambridge Healthtech Institute, the Pharmaceutical Strategy Series (http://www.PharmaSeries.com) produces executive-level conferences that bring together R&D leaders and corporate executives to assess business opportunities, enhance corporate value, and forecast the economic and regulatory landscape within the rapidly changing pharmaceutical & biotechnology industries. PSS conferences are uniquely designed to maximize peer-to-peer networking and idea sharing.
Cambridge Healthtech Institute
# # #